Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $57,043 | 11 | 97.1% |
| Travel and Lodging | $1,069 | 3 | 1.8% |
| Food and Beverage | $605.41 | 5 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $54,321 | 15 | $0 (2024) |
| Integra LifeSciences Corporation | $4,000 | 1 | $0 (2021) |
| Viz.ai, Inc. | $396.38 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,534 | 5 | Novo Nordisk Inc ($28,534) |
| 2023 | $10,688 | 3 | Novo Nordisk Inc ($10,688) |
| 2022 | $15,406 | 9 | Novo Nordisk Inc ($15,099) |
| 2021 | $4,089 | 2 | Integra LifeSciences Corporation ($4,000) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug) | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| Category: Diabetes | ||||||
| 07/04/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $2,625.00 | General |
| 02/08/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $34.18 | General |
| 01/02/2024 | Novo Nordisk Inc | Victoza (Drug) | Consulting Fee | Cash or cash equivalent | $15,375.00 | General |
| Category: Diabetes | ||||||
| 01/02/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Consulting Fee | Cash or cash equivalent | $9,375.00 | General |
| Category: Diabetes | ||||||
| 08/15/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 01/03/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $4,875.00 | General |
| 01/03/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $4,312.50 | General |
| 06/17/2022 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $5,270.00 | General |
| 06/09/2022 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,190.00 | General |
| 05/18/2022 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $7,395.00 | General |
| 05/18/2022 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $382.78 | General |
| 05/18/2022 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $375.00 | General |
| 05/18/2022 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $311.44 | General |
| 05/18/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $174.85 | General |
| 02/15/2022 | Viz.ai, Inc. | Viz.AI LVO (Device) | Food and Beverage | Cash or cash equivalent | $169.00 | General |
| Category: Care Coordination | ||||||
| 02/09/2022 | Viz.ai, Inc. | Viz.AI LVO (Device) | Food and Beverage | Cash or cash equivalent | $137.91 | General |
| Category: Care Coordination | ||||||
| 11/30/2021 | Viz.ai, Inc. | Viz.AI LVO (Device) | Food and Beverage | Cash or cash equivalent | $89.47 | General |
| Category: Care Coordination | ||||||
| 04/15/2021 | Integra LifeSciences Corporation | CEREBROFLO EVD CATHETER SET (Device) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: NEURO CRITICAL CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 131 | 180 | $89,995 | $18,490 |
| 2022 | 7 | 115 | 215 | $82,113 | $19,797 |
| 2021 | 4 | 76 | 100 | $27,775 | $8,916 |
| 2020 | 7 | 167 | 309 | $73,590 | $23,588 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 36 | 36 | $42,100 | $6,475 | 15.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 35 | $23,975 | $5,131 | 21.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 22 | $7,810 | $2,213 | 28.3% |
| 93886 | Complete ultrasound of within the brain blood flow | Facility | 2023 | 13 | 53 | $5,655 | $1,882 | 33.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 17 | 17 | $6,205 | $1,653 | 26.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 17 | $4,250 | $1,137 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 29 | $14,355 | $4,431 | 30.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 21 | 21 | $23,205 | $3,854 | 16.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $13,700 | $3,276 | 23.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 38 | $13,490 | $3,255 | 24.1% |
| 93886 | Complete ultrasound of within the brain blood flow | Facility | 2022 | 11 | 73 | $7,598 | $2,645 | 34.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 23 | $5,750 | $1,391 | 24.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 11 | 11 | $4,015 | $944.68 | 23.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 25 | 46 | $11,536 | $3,623 | 31.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 26 | 27 | $7,900 | $2,541 | 32.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 14 | $6,643 | $2,146 | 32.3% |
| 93892 | Ultrasound scanning for blood clot detection in head and neck vessel blood flow (inside the brain) | Facility | 2021 | 11 | 13 | $1,697 | $604.37 | 35.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 33 | 81 | $17,333 | $6,789 | 39.2% |
| 93886 | Ultrasound scanning of head and neck vessel blood flow (inside the brain) | Facility | 2020 | 20 | 110 | $11,120 | $4,166 | 37.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 22 | 22 | $9,473 | $2,671 | 28.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 16 | 16 | $6,673 | $2,596 | 38.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 13 | 13 | $10,270 | $2,237 | 21.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 24 | 26 | $7,608 | $2,150 | 28.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 26 | 28 | $8,193 | $1,951 | 23.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 13 | 13 | $2,920 | $1,029 | 35.2% |
About Dr. Adam De Havenon, MD
Dr. Adam De Havenon, MD is a Neurology healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2009. The National Provider Identifier (NPI) number assigned to this provider is 1487897898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam De Havenon, MD has received a total of $58,717 in payments from pharmaceutical and medical device companies, with $28,534 received in 2024. These payments were reported across 19 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($57,043).
As a Medicare-enrolled provider, De Havenon has provided services to 489 Medicare beneficiaries, totaling 804 services with total Medicare billing of $70,791. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Vascular Neurology
- Location New Haven, CT
- Active Since 04/15/2009
- Last Updated 04/01/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1487897898
Products in Payments
- Victoza (Drug) $15,375
- Rybelsus (Drug) $9,375
- CEREBROFLO EVD CATHETER SET (Device) $4,000
- Ozempic (Drug) $1,125
- Viz.AI LVO (Device) $396.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in New Haven
Sharon Stoll, D.o, D.O
Neurology — Payments: $782,631
Dr. David Russell, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $390,295
Dr. Kenneth Marek, Md, MD
Neurology — Payments: $293,594
David Hafler, Md, MD
Neurology — Payments: $133,003
Stephen Waxman, Md, MD
Neurology — Payments: $125,575
Imran Quraishi, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $107,014